Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

- 542665 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 We would like to inform you that the management of Neogen Chemicals Limited will be participating in the KIE's India Chemicals Forum (Kotak) on December 2, 2021. The discussion will be under the purview of Neogen Chemicals' Q2&H1 FY22 Earnings Presentation which has already been uploaded on the websites of BSE Limited and National Stock Exchange of India Limited and also on the Company's website www.neogenchem.com .
30-11-2021
Bigul

Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Q2H1FY22- Earnings Call Transcript.
15-11-2021
Bigul

Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 (6) of the Listing Regulations, we would like to inform you that the management of Neogen Chemicals Limited will be participating in the broker conferences. The discussion will be under the purview of Neogen Chemicals' Q2&H1; FY22 Earnings Presentation which has already been uploaded on the websites of BSE Limited and National Stock Exchange of India Limited and also on the Company's website www.neogenchem.com .
11-11-2021
Bigul

Q2FY22 Quarterly Result Announced for Neogen Chemicals Ltd.

 Highlights Neogen Chemicals Limited (Neogen) demonstrated strong performance during the quarter and the half year ending 30th September, 2021. The Company recorded accelerated revenue momentum amounting to Rs. 113.2 crore in Q2 FY22, as compared to Rs. 82.0 crore in the corresponding quarter last year, higher by 38%. This was steered by higher capacity utilization led by positive contribution from Phase | expansion. Enhanced EBITDA performance was achieved due to better utilization of plants post Phase | expansion. Profit after tax (PAT) stood at Rs. 11.2 crore during the quarter as compared to Rs. 7.4 crore in Q2 FY21. PAT was bolstered by strong contribution from key product categories and expanded capacities. Reduction in effective tax rate due to higher revenues from the SEZ facility positively contributed to PAT growth. Earnings per share for the quarter stood at Rs. 4.8 per share (Rs. 3.2 per share in Q2 FY21). Commenting on the Q2 & H1 FY22 performance, Mr. Haridas Kanani, Chairman & Managing Director, Neogen Chemicals said: “l am pleased to share that we have navigated through numerous headwinds during the quarter under review to deliver a solid performance. While revenues increased by 38% during this period, PAT registered gains of 51%. This was possible due to our efforts of running the facilities at higher utilization levels supported by incremental contribution from Phase | expansion. This was further bolstered by our relentless emphasis on product & process innovation as well as our adherence to volumes committed to our customers. In a significant development, we commenced Phase | commercial operations of Organic Chemicals at full scale at Dahej SEZ in September 2021. With this, we will be able to focus on niche complex chemicals that require multiple steps which will enhance our earnings profile. Given the robust demand visibility, we expedited construction at our Phase II expansion project and commissioned it in October 2021. Phase II expansion was earlier planned to come on stream towards the end of the current year. | thank the entire project management team that executed this in a short span of time. Moreover, we are undertaking some exciting initiatives in the lithium-ion battery materials segment to capitalize on the strong demand trajectory and expand our addressable market size. Overall, | am elated with the growth prospects in the Indian chemical industry. Our focus will be to deliver profitable performance given our strengths in the chosen chemistries. All in all, we are well poised to leverage the present opportunities and further strengthen our position in the market.” Result PDF
02-11-2021
Bigul

- 542665 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Press Release on Q2H1FY22 results
30-10-2021
Bigul

Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Q2 H1 FY22 Earnings Presentation.
30-10-2021
Bigul

- 542665 - Outcome Of Board Meeting Held On Saturday, October 30, 2021

 2) Approval of an estimated capex of Rs. 35 crores at Karakhadi Plant for: a) Setting up of a plant with a capacity of producing 250 MT per annum of Electrolyte for Lithium Ion batteries advance chemistry cells; b) Setting up of dedicated Pilot Plant facility to speed up process development and commercialization of specialty chemicals; c) Overall Karakhadi site development.
30-10-2021
Bigul

- 542665 - Outcome Of Board Meeting Held On Saturday, October 30, 2021

 unaudited financial results for the quarter and half year ended September 30, 2021
30-10-2021
Bigul

- 542665 - Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, October 30, 2021.

 1) Approval of unaudited financial results for the quarter and half year ended September 30, 2021 2)Approval of an estimated capex of Rs. 35 crores at Karakhadi Plant for: a) Setting up of a plant with a capacity of producing 250 MT per annum of Electrolyte for Lithium Ion batteries advance chemistry cells;b) Setting up of dedicated Pilot Plant facility to speed up process development and commercialization of specialty chemicals; c) Overall Karakhadi site development.
30-10-2021
Bigul

- 542665 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 (6) of the Listing Regulations, we would like to inform you that the Company will participate in the earnings conference call on Monday, November 1, 2021 at 2.30 p.m. IST for analysts and investors to discuss the Q2 & H1 FY22 results.
28-10-2021
Next Page
Close

Let's Open Free Demat Account